This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing prime editing, how it compares to CRISPR/Cas9, and it's potential in future therapeutics.

Ticker(s): PRME, VRTX, CRSP

Who's the expert?

Associate Professor in the Department of Integrative Biology at University of Colorado. The main interests in our lab revolve around understanding the functions of the enzyme glycogen synthase kinase-3 (Gsk-3) isoforms. We are utilizing a systems biology approach to understanding Gsk-3 function in maintaining pluripotency of embryonic stem cells. We have recently identified a role for Gsk-3 in regulating the methylation of mRNA. This modification, referred to as m6A, affects many aspects of RNA biology, including regulating the stability of mRNA and the translational efficiency. We are currently investigating the mechanisms underlying these effects, and their implications on the biology of stem cells.

Interview Goal
.

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.